Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease

被引:20
|
作者
Rosler, N [1 ]
Wichart, I [1 ]
Jellinger, KA [1 ]
机构
[1] LAINZ HOSP,LUDWIG BOLTZMANN INST CLIN NEUROBIOL,A-1130 VIENNA,AUSTRIA
关键词
cerebrospinal fluid; apolipoprotein E; Alzheimer's disease;
D O I
10.1136/jnnp.60.4.452
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Using a specific enzyme linked immunosorbent assay (ELISA) method, total apolipoprotein E immunoreactivity (tApoE-IR) was measured in premortem lumbar CSF and serum of patients with ''probable'' Alzheimer's disease and in postmortem ventricular CSF of patients with Alzheimer's disease confirmed by necropsy. Concentrations were compared with those from patients with other neurological diseases and controls. The mean serum:lumbar CSF ratio of ApoE-IR was 15.9 suggesting that the main portion of lumbar ApoE-IR is synthesised intrathecally. No significant differences in ApoE-IR between patients with Alzheimer's disease and the other groups were detected in either CSF compartment. In lumbar CSF, there was no correlation between ApoE-IR of patients with Alzheimer's disease and their mini mental stare scores. These results suggest that the diagnostic value of ApoE-IR measurements in CSF of patients with Alzheimer's disease as a single determination is less than that of other markers, in particular tau protein. On the other hand, ApoE determinations could be useful as part of a neurochemical profile of Alzheimer's disease.
引用
收藏
页码:452 / 454
页数:3
相关论文
共 50 条
  • [1] Intra vitam lumbar and post mortem ventricular cerebrospinal fluid immunoreactive interleukin-6 in Alzheimer's disease patients
    Rösler, N
    Wichart, I
    Jellinger, KA
    ACTA NEUROLOGICA SCANDINAVICA, 2001, 103 (02): : 126 - 130
  • [2] Immunoreactive total tau and total apolipoprotein E in cerebrospinal fluid of Alzheimer's disease.
    Rosler, N
    Wichart, I
    Bancher, C
    Jellinger, K
    NEUROPSYCHIATRIE, 1996, 10 (02): : 84 - 86
  • [3] Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients
    Matthew Paul Lennol
    Irene Sánchez-Domínguez
    Inmaculada Cuchillo-Ibañez
    Elena Camporesi
    Gunnar Brinkmalm
    Daniel Alcolea
    Juan Fortea
    Alberto Lleó
    Guadalupe Soria
    Fernando Aguado
    Henrik Zetterberg
    Kaj Blennow
    Javier Sáez-Valero
    Alzheimer's Research & Therapy, 14
  • [4] Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients
    Lennol, Matthew Paul
    Sanchez-Dominguez, Irene
    Cuchillo-Ibanez, Inmaculada
    Camporesi, Elena
    Brinkmalm, Gunnar
    Alcolea, Daniel
    Fortea, Juan
    Lleo, Alberto
    Soria, Guadalupe
    Aguado, Fernando
    Zetterberg, Henrik
    Blennow, Kaj
    Saez-Valero, Javier
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [5] Cerebrospinal Fluid Apolipoprotein E Concentration and Progression of Alzheimer's Disease
    Schmidt, Christian
    Gerlach, Nicole
    Peter, Christoph
    Gherib, Kerim
    Lange, Katharina
    Friede, Tim
    Zerr, Inga
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 43 (04) : 1229 - 1236
  • [6] Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease
    Talwar, Puneet
    Sinha, Juhi
    Grover, Sandeep
    Agarwal, Rachna
    Kushwaha, Suman
    Srivastava, M. V. Padma
    Kukreti, Ritushree
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 360 : 179 - 187
  • [7] Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls
    Hahne, S
    Nordstedt, C
    Ahlin, A
    Nyback, H
    NEUROSCIENCE LETTERS, 1997, 224 (02) : 99 - 102
  • [8] Apolipoprotein E Levels in the Cerebrospinal Fluid of North Indian Patients With Alzheimer's Disease
    Kandimalla, Ramesh J. L.
    Wani, Willayat Yousuf
    Anand, R.
    Kaushal, Alka
    Prabhakar, Sudesh
    Grover, Vinod K.
    Bharadwaj, Neerja
    Jain, Kajal
    Gill, Kiran Dip
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2013, 28 (03): : 258 - 262
  • [9] Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease
    Lefranc, D
    Vermersch, P
    Dallongeville, J
    DaemsMonpeurt, C
    Petit, H
    Delacourte, A
    NEUROSCIENCE LETTERS, 1996, 212 (02) : 91 - 94
  • [10] Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's disease
    Pirttilä, T
    Koivisto, K
    Mehta, PD
    Reinikainen, K
    Kim, KS
    Kilkku, O
    Heinonen, E
    Soininen, H
    Riekkinen, P
    Wisniewski, HM
    NEUROSCIENCE LETTERS, 1998, 249 (01) : 21 - 24